Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115213) titled 'Long-term Effects of Saccharomyces boulardii on Efficacy and Gut Microbiota in IBS-D: A Multicenter, Interventional, Single-Arm Clinical Trial' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Diarrhea-predominant irritable bowel syndrome
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Saccharomyces boulardii intervention group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn...